Trade

with

Lpath Inc
(NASDAQ: LPTN)
AdChoices
3.15
+0.16
+5.35%
After Hours :
-
-
-

Open

3.16

Previous Close

2.99

Volume (Avg)

10.36k (39.14k)

Day's Range

3.10-3.16

52Wk Range

2.75-5.36

Market Cap.

46.70M

Dividend Rate ( Yield )

-

Beta

0.64

Shares Outstanding

15.62M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 7.99M

    • Net Income

    • -6.56M

    • Market Cap.

    • 46.70M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -138.56

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.64

    • Forward P/E

    • -

    • Price/Sales

    • 5.42

    • Price/Book Value

    • 3.55

    • Price/Cash flow

    • -3.32

      • EBITDA

      • -7.40M

      • Return on Capital %

      • -56.77

      • Return on Equity %

      • -84.97

      • Return on Assets %

      • -56.77

      • Book Value/Share

      • 0.84

      • Shares Outstanding

      • 15.62M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 40.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.11

        • Cashflow Estimate

        • 0.16

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -33.90

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 22.79

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -138.56

            • 39.38

            • Net Profit Margin

            • -138.56

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -36.40

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 4.56

              • 2.92

              • Quick Ratio

              • 4.44

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.40

              • 2.21

              • Book Value/Share

              • 0.84

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -3.97

                • 238.10

                • P/E Ratio 5-Year High

                • -14.19

                • 634.30

                • P/E Ratio 5-Year Low

                • -3.60

                • 124.82

                • Price/Sales Ratio

                • 5.51

                • 8.94

                • Price/Book Value

                • 3.61

                • 8.12

                • Price/Cash Flow Ratio

                • -3.32

                • 47.85

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -84.97

                        (-60.30)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -56.77

                        (-8.10)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -84.97

                        (-60.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.41

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -7.59M
                      Operating Margin
                      -95.05
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -3.32
                      Ownership

                      Institutional Ownership

                      49.86%

                      Top 10 Institutions

                      46.84%

                      Mutual Fund Ownership

                      12.13%

                      Float

                      94.24%

                      5% / Insider Ownership

                      48.01%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Franklin Biotechnology Discovery

                      •  

                        672,720

                      • 22.05

                      • 4.43

                      • Franklin Biotechnology Discovery Fund

                      •  

                        437,485

                      • 0.00

                      • 2.81

                      • Allianz Biotechnologie

                      •  

                        234,030

                      • 0.00

                      • 1.49

                      • Pru Ret Small Cap Value/Kennedy SP

                      •  

                        174,578

                      • 2.70

                      • 1.12

                      • Vanguard Total Stock Mkt Idx

                      •  

                        119,849

                      • 0.00

                      • 0.77

                      • FCP OP MEDICAL BioHealthTrends

                      •  

                        77,677

                      • 351.03

                      • 0.50

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        36,191

                      • 0.00

                      • 0.23

                      • APO Medical Opportunities

                      •  

                        31,198

                      • 0.00

                      • 0.20

                      • Vanguard Extended Market Index Fund

                      •  

                        21,008

                      • 0.00

                      • 0.13

                      • PHARMA/wHEALTH

                      •  

                        12,037

                      • 39.37

                      • 0.08

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Hbm Bioventures Cayman Ltd

                      •  

                        2,780,836

                      • +299.80%

                      • 17.80

                      • Franklin Advisers, Inc.

                      •  

                        1,110,205

                      • 0.00%

                      • 7.12

                      • Kennedy Capital Management Inc

                      •  

                        452,269

                      • +0.82%

                      • 2.90

                      • Allianz Global Investors

                      •  

                        234,030

                      • -9.36%

                      • 1.50

                      • Allianz Global Investors U.S. LLC

                      •  

                        234,030

                      • 0.00%

                      • 1.49

                      • Prudential Retirement Ins & Annuity Co

                      •  

                        174,129

                      • -6.83%

                      • 1.30

                      • Columbia Management Company

                      •  

                        138,334

                      • 0.00%

                      • 0.89

                      • Vanguard Group, Inc.

                      •  

                        135,848

                      • 0.00%

                      • 0.87

                      • Dafna Capital Management LLC

                      •  

                        105,000

                      • 0.00%

                      • 0.67

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Lpath, Inc. is a biotechnology company engaged in the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human di...moreseases. It has two product candidates that are in clinical development, and one in pre-clinical evaluation. The Company’s product, iSONEP is the ocular formulation of sonepcizumab, a humanized monoclonal antibody against sphingosine-1-phosphate. iSONEP is administered by intravitreal injection, and has demonstrated multiple mechanisms of action in ocular models of disease, including anti-angiogenesis, anti-inflammatory, anti-fibrotic and anti-vascular permeability. As of March 14, 2014, 135 patients have been enrolled in the Nexus trial, with 25 additional patients requi...morered to complete enrollment. ASONEP is the systemic formulation of sonepcizumab. Based on ASONEP’s safety profile and the observation of stable disease in several late-stage cancer patients, the Company believes that further investigation of ASONEP for efficacy in Phase 2 clinical trials is warranted. Lpathomab, its pre-clinical product candidate, is a mAb against lysophosphatidic acid, a key bioactive lipid that has long been recognized as a significant promoter of cancer-cell growth and metastasis in a broad range of tumor types. The Company is engaged in the antibody manufacturing process development activities and expects to complete Investigational New Drug enabling studies in 2014. The Company has developed functional therapeutic monoclonal antibodies against any bioactive lipid. It has produced these antibodies using its ImmuneY2 technology, a series of proprietary processes it has developed. The Company has an intellectual-property position in the bioactive-lipid area, with 82 issued patents, including 53 foreign patents, and 114 patent applications, including 88 foreign patent applications.lessless

                      Key People

                      Scott R. Pancoast

                      CEO/Director/President

                      Daniel H. Petree

                      Chairman of the Board/Director

                      Dr. Roger A. Sabbadini,PhD

                      Founder/Other Executive Officer/Vice President

                      Gary J.G. Atkinson

                      CFO/Chief Accounting Officer/Secretary/Senior VP

                      Mr. Charles A. Mathews

                      Director

                      • Lpath Inc

                      • 4025 Sorrento Valley Boulevard

                      • San Diego, CA 92121

                      • USA.Map

                      • Phone: +1 858 678-0800

                      • Fax: -

                      • lpath.com

                      Incorporated

                      0

                      Employees

                      24

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: